Chemed Price to Book Ratio 2010-2024 | CHE

Historical price to book ratio values for Chemed (CHE) over the last 10 years. The current price to book ratio for Chemed as of June 27, 2024 is 6.97.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Chemed Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-06-28 542.58 6.92
2024-03-31 641.93 $78.46 8.18
2023-12-31 584.36 $73.69 7.93
2023-09-30 519.00 $67.91 7.64
2023-06-30 540.52 $63.42 8.52
2023-03-31 536.23 $58.84 9.11
2022-12-31 508.62 $53.70 9.47
2022-09-30 434.68 $48.73 8.92
2022-06-30 467.01 $46.16 10.12
2021-12-31 525.58 $41.79 12.58
2021-09-30 461.75 $50.87 9.08
2021-06-30 470.69 $55.59 8.47
2021-03-31 455.81 $58.51 7.79
2020-12-31 527.57 $56.65 9.31
2022-03-31 503.62 $44.74 11.26
2020-09-30 475.47 $50.48 9.42
2020-06-30 446.19 $47.39 9.42
2020-03-31 428.22 $43.28 9.89
2019-12-31 433.88 $45.58 9.52
2019-09-30 412.13 $42.21 9.76
2019-06-30 355.88 $39.05 9.11
2019-03-31 315.38 $37.08 8.51
2018-12-31 278.87 $37.25 7.49
2018-09-30 314.32 $35.67 8.81
2018-06-30 316.21 $34.76 9.10
2018-03-31 267.89 $31.98 8.38
2017-12-31 238.33 $33.69 7.07
2017-09-30 197.92 $30.08 6.58
2017-06-30 200.05 $28.48 7.02
2017-03-31 178.46 $31.30 5.70
2016-12-31 156.47 $32.38 4.83
2016-09-30 137.35 $30.22 4.55
2016-06-30 132.47 $28.69 4.62
2016-03-31 131.39 $29.46 4.46
2015-12-31 145.05 $30.55 4.75
2015-09-30 129.02 $29.12 4.43
2015-06-30 126.53 $28.41 4.45
2014-12-31 101.61 $26.72 3.80
2014-09-30 98.75 $25.57 3.86
2014-06-30 89.74 $25.86 3.47
2014-03-31 85.46 $25.57 3.34
2013-12-31 73.03 $25.53 2.86
2015-03-31 115.03 $28.07 4.10
2013-09-30 67.97 $24.34 2.79
2013-06-30 68.67 $25.93 2.65
2013-03-31 75.62 $25.73 2.94
2012-12-31 64.70 $24.46 2.65
2012-09-30 65.18 $24.73 2.64
2012-06-30 56.69 $23.55 2.41
2012-03-31 58.62 $22.71 2.58
2011-12-31 47.77 $21.71 2.20
2011-09-30 51.13 $21.55 2.37
2011-06-30 60.78 $22.97 2.65
2011-03-31 61.66 $21.91 2.81
2010-12-31 58.66 $21.71 2.70
2010-09-30 52.50 $23.51 2.23
2010-06-30 50.22 $22.61 2.22
2010-03-31 49.87 $21.91 2.28
2009-12-31 43.90 $21.10 2.08
2009-09-30 40.06 $20.26 1.98
2009-06-30 35.94 $19.42 1.85
2009-03-31 35.36 $18.56 1.90
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.250B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.643B 10.07
Quest Diagnostics (DGX) United States $15.257B 15.77
DaVita (DVA) United States $12.405B 15.41
Encompass Health (EHC) United States $8.645B 22.13
Elanco Animal Health (ELAN) United States $7.052B 18.30
Option Care Health (OPCH) United States $4.858B 18.39
RadNet (RDNT) United States $4.352B 90.61
Amedisys (AMED) United States $3.038B 21.52
Astrana Health (ASTH) United States $2.284B 30.89
Addus HomeCare (ADUS) United States $1.870B 26.75
LifeStance Health (LFST) United States $1.866B 0.00
U.S Physical Therapy (USPH) United States $1.403B 37.55
Pennant (PNTG) United States $0.682B 36.05
Aveanna Healthcare Holdings (AVAH) United States $0.492B 0.00
Atai Life Sciences (ATAI) Germany $0.221B 0.00
Daxor (DXR) United States $0.046B 0.00
ATI Physical Therapy (ATIP) United States $0.020B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Novo Integrated Sciences (NVOS) United States $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00